4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000098
Chief Medical Officer sold 7,947 shares at an average $92.38 ($734,145)
- Chief Medical Officer acquired 7,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goncalves Joana · Chief Medical Officer
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,500 | $6.84 | $23,940 | 36,218 | D |
| 2026-09-15 | Exercise or conversion : show line 2 in the form 10b5-1 | +3,500 | $7.80 | $27,300 | 39,718 | D |
| 2026-09-15 | Sale : show line 3 in the form 10b5-1 | −2,384 | $91.10 | $217,173 | 37,334 | D |
| 2026-09-15 | Sale : show line 4 in the form 10b5-1 | −3,150 | $92.03 | $289,890 | 34,184 | D |
| 2026-09-15 | Sale : show line 5 in the form 10b5-1 | −1,366 | $92.99 | $127,023 | 32,818 | D |
| 2026-09-15 | Sale : show line 6 in the form 10b5-1 | −100 | $94.22 | $9,422 | 32,718 | D |
| 2026-09-15 | Sale : show line 7 in the form 10b5-1 | −947 | $95.71 | $90,637 | 31,771 | D |
| Open-market sales · 7,947 sh · avg $92.38 · $734,145 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-15 | Exercise or conversion : show line 8 in the form 10b5-1 Employee Stock Option (right to buy) | −3,500 | 193,563 | D |
| 2026-09-15 | Exercise or conversion : show line 9 in the form 10b5-1 Employee Warrant (right to buy) | −3,500 | 164,992 | D |
Loading xslF345X06/form4.xml…